CoChat

Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review

Open access

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Abstract

Objective: To assess effects of treatment against a hypothesized neuroinflammation in children with symptoms corresponding to the research condition Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) which is not included in current diagnostic systems. Methods: Systematic literature searches were performed (1998 to June 2020) in PubMed, Embase, the Cochrane Library, CINAHL, PsycInfo, and HTA databases. Inclusion criteria: patients (P) were children (<18 years) with PANS; intervention (I)/comparison (C) was use of, versus no use of, anti-inflammatory, antibacterial or immunomodulating treatments; outcomes (O) were health-related quality of life (HRQL), level of functioning, symptom change, and complications. Results: Four randomised controlled trials (RCTs) and three non-RCTs, including 23 to 98 patients, fulfilled the PICO. HRQL was not investigated in any study. Regarding level of functioning, two RCTs investigated antibiotics (penicillin V, azithromycin) and one RCT investigated immunomodulating treatments (intravenous immunoglobulins (IVIG), plasma exchange). Regarding symptoms, two non-RCTs investigated anti-inflammatory treatment (cyclooxygenase (COX) inhibitors, corticosteroids), two RCTs and one non-RCT investigated antibiotics (penicillin V, azithromycin), and two RCTs investigated immunomodulating treatments (IVIG, plasma exchange). Complications, reported in five studies, were consistent with those listed in the summary of products characteristics (SPC). All studies were assessed to have some or major problems regarding directness, the absence of an established diagnosis contributing to clinical diversity in the studied populations. All studies were assessed to have major risk of bias, including selection and detection biases. Due to clinical and methodological diversity, meta-analyses were not performed. Conclusion: This systematic review reveals very low certainty of evidence of beneficial effects, and moderate certainty of evidence of adverse effects, of anti-inflammatory, antibacterial or immunomodulating treatments in patients with symptoms corresponding to the research condition PANS. Available evidence neither supports nor excludes potential beneficial effects, but supports that such treatment can result in adverse effects. Registration: PROSPERO (CRD42020155714).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0253844

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flowchart of studies included in this systematic review.
Fig 1 Flowchart of studies included in this systematic review.CC BY · PubMed Central
Fig 2 Forest plots for the outcomes level of functioning according to CGAS for the comparison antibiotic versus no antibiotic (A), and symptoms according to CY-BOCS for the comparisons IVIG versus no IVIG (B). Due to clinical and methodological diversity, in the absence of an established diagnosis and with major risk of bias in all studies (e.g. selection and detection bias), we refrained from pooling the results.
Fig 2 Forest plots for the outcomes level of functioning according to CGAS for the comparison antibiotic versus no antibiotic (A), and symptoms according to CY-BOCS for the comparisons IVIG versus no IVIG (B). Due to clinical and methodological diversity, in the absence of an established diagnosis and with major risk of bias in all studies (e.g. selection and detection bias), we refrained from pooling the results.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 25

Metadata

Authors
Johnson, M., Ehlers, S., Fernell, E., Hajjari, P., Wartenberg, C., & Wallerstedt, S. M.
Affiliations
  • Sahlgrenska University Hospital (SE)
  • Kungälvs Sjukhus (SE)
Corresponding author
Johnson, Mats
Venue
PLOS ONE
Published
2021-07-01
Volume
16
Issue
7
Pages
e0253844
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3175116915
Cited by
25
References
36
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 2
FWCI
0.50
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
Keywords
pediatric acute-onset neuropsychiatric syndrome, PANS, anti-inflammatory therapy, antibiotic therapy, immunomodulatory therapy, neuroinflammation, children, intravenous immunoglobulin, plasma exchange, antibiotics, penicillin V, azithromycin, corticosteroids, cyclooxygenase inhibitors, health-related quality of life, treatment side effects
MeSH terms
Anti-Inflammatory Agents, Anti-Bacterial Agents, Autoimmune Diseases, Child, Combined Modality Therapy, Glucocorticoids, Humans, Immunologic Factors, Obsessive-Compulsive Disorder, Plasma Exchange, Quality of Life, Randomized Controlled Trials as Topic, Immunoglobulins, Intravenous, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review. https://app.cochat.ai/papers/10.1371/journal.pone.0253844
The paper
Johnson, M., Ehlers, S., Fernell, E., Hajjari, P., Wartenberg, C., & Wallerstedt, S. M. (2021). Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review. PLOS ONE. https://doi.org/10.1371/journal.pone.0253844

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.